German ban on Medtronic TAVI begins today, Edwards makes room for 'compassionate cases'

August 26, 2013 by Arezu Sarvestani

Transcatheter aortic valve implantation systems maker Edwards Lifesciences touts a German legal win forcing rival device maker Medtronic to pull its TAVI systems off the market, starting today.

German ban on Medtronic TAVI begins today, Edwards makes room for 'compassionate cases'

Starting today, medical device giant Medtronic (NYSE:MDT) is banned from selling its CoreValve and CoreValve Evolut transcatheter aortic valve implantation systems in Germany, thanks to a court ruling in favor of rival device maker Edwards Lifesciences (NYSE:EW).

However, Edwards is making some concessions to leave room for physicians to purchase Medtronic devices "where the Edwards SAPIEN XT valve is not indicated, subject to Medtronic's cooperation," according to a company statement.

Sign up to get our free newsletters delivered right to your inbox.

"Edwards will not seek compensation for the valves used in these compassionate cases in Germany, which are estimated to be about 40 per month," the company said.

Comments